Silver nanoparticles (SNP) alone and in combination (Combi) with the antibiotic fluconazole (Flu) were explored for their effective role in controlling Candida albicans. The C. albicans isolates used were identified by amplifying the ITS region of rDNA with primers ITS 5 and ITS 4. The MIC of the SNP and Flu alone and in conjunction with each other were assayed by the micro dilution plate method and checkerboard assay respectively. The synergistic effects of SNP and Flu were established by calculating the fractional inhibitory concentration (FIC) index. The effects of these treatments (½ MIC) on budding and on germ tube formation were determined. The identity of all five isolates as C. albicans was confirmed by molecular analysis of ITS rDN...
Nas últimas décadas vem ocorrendo um aumento significativo de infecções causadas por Candida spp., p...
Abstract Background and objective: In recent years, the resistance of opportunistic fungal strains t...
Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient populatio...
Background and Aim: Recently opportunistic fungus resistance has significantly increased like Candid...
Silver nanoparticles (AgNPs) have been extensively studied because of their anti-microbial potential...
The upsurge of immunocompromised patients has led to extensive study of fungal infections with Candi...
In this study, the antifungal activity of AgNPs was tested against C. tropicalis (pathogen fungi) an...
"Candida albicans is the most common fungal pathogen in humans, and recently some studies have repor...
Candida albicans is the most common fungal pathogen in humans, and recently some studies have report...
In this study, we investigated the antifungal effects of silver nanoparticles (Ag-Nps) on Candida al...
Candida albicans is the most common fungal pathogen in humans, and recently some studies have report...
Background and Objectives: Candida is a genus of yeasts and is considered as the most common cause o...
Objectives: Fungal infections in immunocompromised patients have been contributing to the increasing...
The aim of present study was calculate the Minimum inhibitory concentrations (MICs) of silver nanopa...
The aim of this study was to evaluate the effect of silver nanoparticles (SN) against Candida albica...
Nas últimas décadas vem ocorrendo um aumento significativo de infecções causadas por Candida spp., p...
Abstract Background and objective: In recent years, the resistance of opportunistic fungal strains t...
Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient populatio...
Background and Aim: Recently opportunistic fungus resistance has significantly increased like Candid...
Silver nanoparticles (AgNPs) have been extensively studied because of their anti-microbial potential...
The upsurge of immunocompromised patients has led to extensive study of fungal infections with Candi...
In this study, the antifungal activity of AgNPs was tested against C. tropicalis (pathogen fungi) an...
"Candida albicans is the most common fungal pathogen in humans, and recently some studies have repor...
Candida albicans is the most common fungal pathogen in humans, and recently some studies have report...
In this study, we investigated the antifungal effects of silver nanoparticles (Ag-Nps) on Candida al...
Candida albicans is the most common fungal pathogen in humans, and recently some studies have report...
Background and Objectives: Candida is a genus of yeasts and is considered as the most common cause o...
Objectives: Fungal infections in immunocompromised patients have been contributing to the increasing...
The aim of present study was calculate the Minimum inhibitory concentrations (MICs) of silver nanopa...
The aim of this study was to evaluate the effect of silver nanoparticles (SN) against Candida albica...
Nas últimas décadas vem ocorrendo um aumento significativo de infecções causadas por Candida spp., p...
Abstract Background and objective: In recent years, the resistance of opportunistic fungal strains t...
Non-albicans Candida (NAC) species cause 35-65% of all candidaemias in the general patient populatio...